Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.55 |
| ▸ | FYN | P06241 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA3 | P07451 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA6 | P23280 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26841753 | 0.88 | LCK (0.53) | LCKFYNHSD17B10TSHRCA12 | |
| SCHEMBL2537783 | 0.88 | LCK (0.53) | LCKFYNHSD17B10TSHRCA12 | |
| SCHEMBL27506179 | 0.88 | LCK (0.53) | LCKFYNHSD17B10TSHRCA12 | |
| SCHEMBL31371830 | 0.85 | LCK (0.50) | LCKFYNHSD17B10TSHRCA12 | |
| SCHEMBL3686898 | 0.85 | LCK (0.50) | LCKFYNHSD17B10TSHRCA12 | |
| SCHEMBL2796102 | 0.84 | HSD17B10 (0.44) | LCKFYNHSD17B10TSHRCA12 | |
| SCHEMBL30294917 | 0.83 | LCK (0.48) | LCKFYNHSD17B10TSHRCA12 | |
| SCHEMBL1250619 | 0.83 | LCK (0.48) | LCKFYNHSD17B10TSHRCA12 | |
| SCHEMBL15719837 | 0.83 | LCK (0.48) | LCKFYNHSD17B10TSHRCA12 | |
| SCHEMBL851686 | 0.83 | LCK (0.48) | LCKFYNHSD17B10TSHRCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3939577-A1 | PHARMACEUTICAL COMPOSITION COMPRISING A GLUCOPYRANOSYL-SUBSTITUTED BENZENE DERIVATIVE | Boehringer Ingelheim International GmbH (DE) | 2022-01-19 | — | — | EP | disclosed |
| EP-3284734-B1 | METHOD FOR PRODUCING 2-HALOGENATED BENZOIC ACIDS | SUMITOMO SEIKA CHEMICALS (JP) | 2021-12-01 | — | — | EP | disclosed |
| US-10364206-B2 | Method for producing 2-halogenated benzoic acids | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2019-07-30 | — | — | US | disclosed |
| US-20180086687-A1 | METHOD FOR PRODUCING 2-HALOGENATED BENZOIC ACIDS | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2018-03-29 | — | — | US | disclosed |
| EP-3284734-A1 | METHOD FOR PRODUCING 2-HALOGENATED BENZOIC ACIDS | Sumitomo Seika Chemicals CO. LTD. (JP) | 2018-02-21 | — | — | EP | disclosed |
| WO-2009027785-A2 | 1, 3-OXAZOLE DERIVATIVES AS CETP INHIBITORS | PFIZER PRODUCTS INC. (US) | 2009-03-05 | — | — | WO | disclosed |
| WO-2009027785-A2 | 1, 3-OXAZOLE DERIVATIVES AS CETP INHIBITORS | PFIZER PRODUCTS INC. (US) | 2009-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180086687-A1 | METHOD FOR PRODUCING 2-HALOGENATED BENZOIC ACIDS | HAO2, HACL2, GABBR2 | LCK 4560/4885FYN 2560/4885HSD17B10 140/4885 |
| US-10364206-B2 | Method for producing 2-halogenated benzoic acids | HAO2, HACL2, GABBR2 | LCK 4560/4885FYN 2560/4885HSD17B10 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.